Joe Bernardo has been named chairman of the board of SeraCare Life Sciences. Bernardo is also an operating partner at Linden Capital Partners, the equity investors behind SeraCare. Prior to these roles, he served as president of the next-generation sequencing and oncology division at Thermo Fisher Scientific. He has also worked for Siemens Healthcare, where he was senior vice president of the central lab business unit, and Abbott Laboratories.
Giulia Kennedy, Jessica Meng